10X Genomics(TXG)

PLEASANTON, CABiotechnology4 H-1B visas (FY2023)

Focus: 10X Genomics is a public genomics platform company headquartered in Pleasanton, CA, providing sequencing and analysis tools for research and clinical applications across neurology, oncology, and ophthalmology. As a platform provider, they operate in the enabling technology segment rather than traditional drug development.

Neurology Oncology Ophthalmology

Profile data last refreshed 2h ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

29+15 this month

Growing — net +15 jobs in 30d

37 jobs added vs 22 removed. Steady team buildout.

Should You Work at 10X Genomics?

AI assessment

10X Genomics offers exposure to high-growth genomics technology with public-company stability, but recent layoffs and persistent losses warrant caution about career continuity.

Why Work Here

Platform-driven business model with 20% YoY revenue growth ($619M in FY2025 vs $516M in FY2024) provides stability in a capital-efficient tech-enabled sector

Data completeness

4/9 — Basic

Company HealthStrong

Pipeline

Early-stage

0 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Revenue

$619M

Recent News · 10X Genomics(3)

FinancialSEC 8-K

Mar 9, 2026

8-K Filing: Xilio Therapeutics, Inc. (XLO) (CIK 0001840233) — EX-99.1

EX-99.1

Help build intelligence for 10X Genomics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

44% R&D intensity signals commitment to innovation and technical depth, appealing to scientists and engineers seeking cutting-edge genomics work

Public company status offers liquidity, established benefits, and career visibility in the rapidly growing genomics and precision medicine space

Watch Out For

Recent layoffs totaling 93 employees (May 2025) signal organizational restructuring and potential headcount volatility despite revenue growth
Negative net income of $-255M in FY2025 indicates the company is not yet profitable despite strong revenue, raising long-term sustainability questions
Limited hiring in core R&D (only 1 open role) despite 44% R&D spend suggests consolidation or automation of research functions

Generated by Claude from 10X Genomics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

FinancialSEC 8-K

Feb 25, 2026

8-K Filing: CareDx, Inc. (CDNA) (CIK 0001217234) — EX-99.1

EX-99.1

Interview Prep Quick Facts

H-1B (2023): 4 approvals

Publications: 25 in PubMed

SEC Filings: 2 available

Open Roles: 29 active jobs

Financials (FY2025)

Revenue

$619M20%

R&D Spend

$270M(44%)2%

Net Income

-$255M

Hiring Trend

Actively Hiring

Open Roles

+11

Added

-5

Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

80%

Rate

Source: USCIS H-1B Employer Data Hub

Risk Signals

WARN Act Layoff Notices (3)

2025-05-06

3 employees affected— CA

2025-05-06

2 employees affected— 6210 Stoneridge Mall Road Pleasanton CA 94588, CA

2025-05-06

88 employees affected— 6230 Stoneridge Mall Road Pleasanton CA 94588, CA

Source: state DOL filings, aggregated via Big Local News

Research Publications(10)

Recent peer-reviewed publications with author affiliations at this company

Diversity and immune dynamics of choroid plexus macrophages are shaped by distinct developmental origins.

Nature neuroscience

2026

PMID:41566006

Publisher Correction: Diversity and immune dynamics of choroid plexus macrophages are shaped by distinct developmental origins.

93 employees laid off across three WARN filings in May 2025 (88 + 3 + 2), concentrated at Pleasanton headquarters, indicating substantial organizational restructuring despite revenue growth.

Recent large-scale layoffs signal aggressive cost-cutting and organizational restructuring; candidates should clarify department stability and headcount plans during interviews before accepting offers.

Showing 5 of 10 publications

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

10X Genomics(TXG)

Should You Work at 10X Genomics?

Why Work Here

Recent News · 10X Genomics(3)

Watch Out For

Open Jobs (29)

Head of Data and Insights Business

Senior Research Associate- Diagnostic Assay Development

Scientist 2-Spatial Biology and Biophysics

Sourcing Manager, Indirect Procurement IT (Contract)

Senior Research Associate II, Assay Productization (P-5128)

Field Application Scientist- Bay Area, CA

Staff Mechanical Engineer

Senior Manufacturing Engineering Technician

Senior Workday Analyst

Staff Data Scientist, Sales Analytics

District Sales Manager, Gulf Coast

Director of Sales Training

Senior Executive Assistant

P-5010 Scientist II, Reagents Sustaining and Applications

Clinical Laboratory Scientist, (Technical Supervisor)

Senior Product Manager, Growth - Web & E-commerce

Sr. Program Manager

Staff Mechanical Engineer, Consumables

Global Commercial Education Manager

Scientist II, Clinical Bioinformatics

Director, Global Digital Marketing

Financials (FY2025)

Hiring Trend

Visa Sponsorship

Risk Signals

WARN Act Layoff Notices (3)

Research Publications(10)